LY 2157299 (CAS: 700874-72-2)
|
SKU-Pack Size | Availability | Size | Price | |
EBC51016-1ML | In Stock | 1mL(10mM in DMSO) | ¥790.00 | |
EBC51037-5MG | In Stock | 5mg | ¥690.00 | |
EBC51038-10MG | In Stock | 10mg | ¥990.00 | |
EBC51038-25MG | In Stock | 25mg | ¥1990.00 | |
EBC51037-50MG | In Stock | 50mg | ¥2990.00 |
Please Select The Country You Are In To Find Your Local Distributor. |
北京美瑞克生物科技有限公司 | Phone: +86 010-62890160 / 13691184142(微信同号) | |
2 / F, 128 malianwa North Road, Haidian District, | E-mail: mrkbio@163.com | |
China | Beijing China | Website: www.mrkbio.com |
Product Information | |||||||||||||||||||||
Synonym(s) | LY 2157299, LY-2157299, Galunisertib | ||||||||||||||||||||
Chemical Name | 4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide | ||||||||||||||||||||
Application | LY2157299 is a potent TGF β RI inhibitor | ||||||||||||||||||||
CAS Number | 700874-72-2 | ||||||||||||||||||||
Purity | ≥98.0% | ||||||||||||||||||||
Molecular Weight | 369.42 | ||||||||||||||||||||
Molecular Formula | C₂₂H₁₉N₅O | ||||||||||||||||||||
SMILES | CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N | ||||||||||||||||||||
Target & IC50 | Flk-1: IC50 = 442 nM TGFβ RI: IC50 = 56 nM |
||||||||||||||||||||
Solubility | DMSO: 74 mg/mL (200.31 mM) | ||||||||||||||||||||
Preparing Stock Solutions |
|
||||||||||||||||||||
Shipping | Gel Pack | ||||||||||||||||||||
Storage | Store at -20°C | ||||||||||||||||||||
Research Use | For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use. |
Product Description | |
LY 2157299 is a potent inhibitor of Transforming Growth factor-Beta Receptor I (TGF-BetaR). TGF-Beta1 is involved in the control of cell growth, proliferation, differentiation, and apoptosis. LY2157299 is reported to disrupt Smad-2 phosphorylation in Human Umbilical Vein Endothelial Cells (HUVEC) and inhibit the growth and migration of tumor cells. |
Specific Protocols | |